["{\n\"step_by_step_thinking\": \"The patient is being considered for treatment with raloxifene due to her low bone mineral density. Raloxifene is a selective estrogen receptor modulator (SERM) commonly used to prevent osteoporotic fractures in postmenopausal women. One of the potential risks associated with raloxifene use is pulmonary embolism. The patient has no history of deep vein thrombosis or pulmonary embolism, but this risk needs to be considered in her decision-making process.\",\n\"answer_choice\": A"]